Propanc Biopharma, Inc. (Nasdaq: PPCB) announced it has completed the first tranche of its $5.0 million share repurchase program, purchasing ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE